Bilateral lateral rhinotomy incisions for medial maxillectomies in the management of pediatric invasive fungal sinusitis.
OBJECTIVE
To determine if simultaneous, bilateral lateral rhinotomies for medial maxillectomies would result in central skin or bone loss in pediatric patients with invasive fungal disease.


METHODS
Retrospective chart review.


METHODS
Tertiary care children's hospital.


METHODS
Three children underwent surgery between April 1996 and June 1998. Ages at treatment ranged from 11 to 14 years. All had bilateral, biopsy-proven invasive fungal disease of the lateral walls of the nose. All were undergoing chemotherapy for acute lymphocytic leukemia (ALL) or acute myelocytic leukemia (AML).


METHODS
Bilateral lateral rhinotomies for medial maxillectomy. Two of 3 also had simultaneous total septectomy.


METHODS
Skin survival and patient survival.


RESULTS
All three patients had bilateral simultaneous medial maxillectomy for invasive fungal disease in the presence of profound pancytopenia secondary to treatment of leukemia. One patient had minor nasal edema postoperatively, but none showed any loss of the central nasal skin or facial skeleton. All patients survived the invasive fungal disease with follow-up of at least 24 months. All patients underwent multiple debridements after the original surgery, and 3 of 6 eyes had permanent epiphora requiring dacryocystorhinostomies.


CONCLUSIONS
Bilateral simultaneous lateral rhinotomies are safe in children and did not result in any central skin loss. Aggressive bilateral surgery for invasive fungal disease is compatible with a good esthetic outcome and long-term survival.
Malhotra
P S
PS
Department of Otolaryngology-Head & Neck Surgery, University of Minnesota Hospital, Minneapolis, Minnesota, USA.
Danahey
D
D
Sidman
J
J
D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D008297:Male; D008443:Maxillary Sinus / Q000601:surgery*; D015523:Maxillary Sinusitis / Q000276:immunology / Q000382:microbiology* / Q000601:surgery*; D009181:Mycoses / Q000276:immunology / Q000601:surgery*; D009666:Nose / Q000601:surgery*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology; D012189:Retrospective Studies